Kimberly Blackwell is a director of Century Therapeutics Inc.
Person profile
Roles
Address
New York, New York
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Zentalis Pharmaceuticals, Inc.
5 Feb 24
4
Zentalis Pharmaceuticals, Inc.
13 Nov 23
4
Century Therapeutics, Inc.
29 Jun 23
4
Monte Rosa Therapeutics, Inc.
15 Jun 23
4
Zentalis Pharmaceuticals, Inc.
1 Feb 23
4
Monte Rosa Therapeutics, Inc.
16 Jun 22
4
Century Therapeutics, Inc.
10 Jun 22
4
Zentalis Pharmaceuticals, Inc.
20 May 22
4
Zentalis Pharmaceuticals, Inc.
5 Jan 22
4
Zentalis Pharmaceuticals, Inc.
2 Dec 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Feb 24 | ZNTL Zentalis Pharmaceuticals | Common Stock | Payment of exercise | Dispose F | No | No | 11.69 | 20,655 | 241.46 k | 484,145 |
1 Feb 24 | ZNTL Zentalis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 250,000 | 0.00 | 504,800 |
1 Feb 24 | ZNTL Zentalis Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 11.69 | 250,000 | 2.92 mm | 250,000 |
13 Nov 23 | ZNTL Zentalis Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 10.2896 | 5,000 | 51.45 k | 254,800 |
27 Jun 23 | IPSC Century Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.19 | 44,000 | 140.36 k | 44,000 |
14 Jun 23 | GLUE Monte Rosa Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 6.59 | 20,500 | 135.10 k | 20,500 |
1 Feb 23 | ZNTL Zentalis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 244,800 | 0.00 | 249,800 |
1 Feb 23 | ZNTL Zentalis Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 23.65 | 355,200 | 8.40 mm | 355,200 |